Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
NCT07613567Phase 3Not yet recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Sep 2026
- Primary completion
- Aug 2032
- Countries
- 1
01
Overview
A Phase 3 trial of iparomlimab + tuvonralimab in Cervical Cancer (CC), sponsored by Fujian Medical University Cancer Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
iparomlimab + tuvonralimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07613567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07613567.